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Novel microfluidic technologies being developed for
portable diagnostic systems have potential for use in TB
serodiagnosis or as platforms for cell and biomolecular
assays. Using microfluidics, with its miniaturized chan-
nels and reservoirs for portable devices, offers many
advantages, including: high surface-to-volume ratio; a
low Reynolds number; increased speed of reaction;
reduced cost of reagents; decreased cost of power con-
sumption; precise mixing/dosage and heating. Its inte-
gration capability offers advantages as well, such as low
manufacturing cost and multiplex capability, i.e. an
increased number of parameters can be monitored per
sample.
Two microfluidic platforms may be helpful in protein
microarray analysis. Microfluidic electrical sensing plat-
forms are capable of detecting antigen/antibody binding
in real time. The development of this platform will
allow for faster detection of certain diseases with a
patient’s sample compared to standard techniques such
as ELISA. This platform requires microchannel-sealed
microarrays with electrical detection capability. By mea-
suring electrical charges, the scientists can determine
protein-binding activity. Additionally, microfluidic col-
orimetric platforms are being developed using acoustic
micromixing instead of fluorescence scanning. The pro-
cess uses a scanner that detects an enzyme–based
change of color that allows measurement of the protein-
binding event. Our team is developing these platforms
using components that have very small energy require-
ments, which means the device may not require bat-
teries to operate.
A ‘lab-in-a-droplet’ technique using digital microflui-
dics rather than using microarrays, which produce a
static substrate, diffuses samples into as many as
millions of droplets, presenting a three-dimensional
picoliter reactor array. This process has several advan-
tages including: rapid mixing, homogeneous reactions,
precise control of volumes and concentrations, and an
ability to mimic cellular reactions. Our team is using
this technique in the development of lipoplexes and to
encapsulate a cell in a single droplet. Lastly, a platform
is under development for cell sorting using electrodes to
track cells in order to determine what function the cell
will take on.
In addition to its value in the diagnosis of TB, micro-
fluidics technology has several other applications,
including: broader distribution of new assays to biologic
labs, rapid analyses in the field for epidemiologic studies,
and the ability to study hybridization of molecules on
microarrays. For example, Lab-on-a-chip technologies
are an excellent vehicle for integrating diagnostic and
therapeutic functions. Digital (droplet) microfluidics
enables high throughput cellular and molecular assays
and cell sorting technologies enable more practical
cellular analyses and therapies.
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